WolverHeme Happy Hour Podcast Por Bernard Marini Anthony Perissinotti et al. arte de portada

WolverHeme Happy Hour

WolverHeme Happy Hour

De: Bernard Marini Anthony Perissinotti et al.
Escúchala gratis

Acerca de esta escucha

 Welcome to WolverHeme Happy Hour! This is a podcast dedicated to all things hematology! We discuss new data, debate controversial therapies, and talk about new and exciting research. While we nerd out about data, we'll have a few drinks! Disclaimer: The views and opinions expressed on this podcast are solely those of the podcasters and guests and do not reflect the views or opinions of our employers or other affiliations.Bernard Marini, Anthony Perissinotti, et al. Enfermedades Físicas Hygiene & Healthy Living
Episodios
  • Episode 36: ODAC - Our Decisions Are Confusing

    Episode 36: ODAC - Our Decisions Are Confusing
    May 28 2025

    In this episode, Bernie and Anthony are joined by the Myeloma Man Dr. Manni Mohyuddin and lymphoma expert Dr. David Russler-Germain to discuss the very recent ODAC decisions on the STARGLO (glofitamab + GemOx) and AQUILA (daratumumab for smoldering multiple myeloma) trials. Did ODAC do their due diligence, or are there double standards? There is a lot to unpack in this episode!

    Más Menos
    43 m
  • CSO Encore Video Presentation - SWOG1826 & STARGLO Trials Critically Examined

    CSO Encore Video Presentation - SWOG1826 & STARGLO Trials Critically Examined
    May 5 2025

    This is a special encore video presentation of Anthony and Bernie teaming up with the Common Sense Oncology Journal Club series to discuss the SWOG1826 and STARGLO clinical trials. Tycel Phillips, MD, and Manju Sengar, MD join Anthony and Bernie for a great discussion of the trials and how they should impact practice!


    Join the Common Sense Oncology movement here! https://commonsenseoncology.org/

    Más Menos
    1 h y 11 m
  • Dex and the Cytokine City: Managing CRS with Bispecifics

    Dex and the Cytokine City: Managing CRS with Bispecifics
    Apr 7 2025

    In this episode, Bernie and Anthony are joined by 3 hematology pharmacists - James Davis, PharmD, BCOP; Victoria Nachar, PharmD, BCOP; and Justine Preedit, PharmD, BCOP - to discuss the optimal management of CRS in patients receiving bispecific antibodies!


    Inspired by this recent paper:

    https://www.nature.com/articles/s41408-025-01222-y
    Más Menos
    1 h
Todavía no hay opiniones